Mutational Alterations of the p16CDKN2A Tumor Suppressor Gene Have Low Incidence in Mesenchymal Chondrosarcoma
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics | January 5, 2018 | Volume: 12 | Issue: 1 | Pages: 5-10
10.3727/000000001108747381
| PMID 11061340